Adicet Bio (ACET) vs Xilio Therapeutics (XLO)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Xilio Therapeutics (XLO) has outperformed Adicet Bio (ACET) over the past year, losing 21.7% versus a loss of 54.7%. Xilio Therapeutics is the larger company by market cap ($59.3 million vs $57.9 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ACET | XLO |
|---|---|---|
| Share price | $6.18 | $9.01 |
| Market cap | $57.85M | $59.29M |
| 1-day change | -1.12% | +0.11% |
| YTD return | -26.60% | +0.56% |
| 1-year return | -54.72% | -21.71% |
| 5-year return | -95.20% | — |
| EPS (TTM) | $-10.32 | $-0.60 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $17.44 | $12.59 |
| 52-week low | $6.01 | $6.47 |
| Distance from 52-week high | -64.56% | -28.41% |
| Average volume | 165.53K | 20.06K |
| Shares outstanding | 9.36M | 6.58M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- XLO has outperformed ACET by 33.0 percentage points over the past year.
ACET vs XLO FAQ
Which is bigger, Adicet Bio or Xilio Therapeutics?
Xilio Therapeutics (XLO) is larger, with a market capitalization of $59.29M compared with $57.85M for Adicet Bio (ACET).
Which stock has performed better over the past year, ACET or XLO?
XLO returned -21.71% over the past 12 months, compared with -54.72% for ACET (price return, excluding dividends). Past performance does not predict future results.
Are Adicet Bio and Xilio Therapeutics in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.